Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials

Overview

Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug manufacturing and digital health investment.

News

Press release 3 months ago
ViewsML CEO Details AI-Driven Virtual Multiplexing Strategy Following $4.9M Seed Round
Following an oversubscribed $4.9 million seed round, supported by Debiopharm alongside lead investor Wittington Ventures, Mayo Clinic, and Continuum
Read more
Report
Blog 3 months ago
Nucleai Joins CellCarta's Digital Pathology and AI Consortium to Accelerate Platform-Agnostic Biomarker Innovation Across Drug Development
In a major step forward for drug development, Nucleai has joined CellCarta's newly launched Consortium, a curated ecosystem of leading digital pathology, artificial intelligence, and precision diagnostics innovators. By combining CellCarta's pathologist-d
Read more
Report
Blog 4 months ago
VeriSIM Life Formalizes Research Collaboration with FDA/NCTR, Advancing the Next Generation of Mechanistic AI for Drug Development
VeriSIM Life has signed a Material Transfer Agreement (MTA) with the FDA's National Center for Toxicological Research (FDA/NCTR), establishing an official framework to leverage its hybrid AI platform, BIOiSIM, to help narrow the persistent translational g
Read more
Report
Press release 6 months ago
ViewsML Secures Funding to Accelerate Commercialization of AI-Driven Virtual Biomarker Staining Platform
ViewsML has successfully closed an oversubscribed $4.9M seed round, marking a major milestone in their mission to transition tissue analysis from a manual
Read more
Report
Blog 7 months ago
Iktos and Chemspeed Partner to Bring AI-Orchestrated Laboratory Automation to Pharmaceutical R&D
Iktos and Chemspeed Technologies (a Bruker company) recently announced a collaboration to bridge the gap between AI-driven molecule design and physical chemical synthesis. As a strategic investor in Iktos, we are pleased to see their orchestration technol
Read more
Report
Blog 8 months ago
BC Platforms partners with OmicsBank to expand access to large-scale real-world and multi-omics data from India and the UAE
BC Platforms has announced a strategic partnership with OmicsBank to enable access to longitudinal and multi-modal real-world clinical and multi-omics datasets from emerging markets. The collaboration adds approximately 12 million patient lives from India
Read more
Report
Blog 8 months ago
Nucleai Enables Spatial Biology Research in Nature Communications Study on Lung Cancer Treatment Response
Nucleai has announced its contribution to a collaborative international study published in Nature Communications exploring how the spatial organization and metabolic characteristics of tumor cells are associated with response and resistance to immunothera
Read more
Report
Blog 9 months ago
Risklick and Citeline Partner to Revolutionize Clinical Trial Protocol Design with AI
Our portfolio company Risklick, a Swiss-based company specializing in AI-driven solutions for clinical trial protocol development, has announced a strategic partnership with Citeline, a leader in clinical solutions for the life sciences industry, to launc
Read more
Report
Blog 9 months ago
Debiopharm Deploys Genialis Software to Advance AI-Based Biomarker Discovery
Debiopharm has deployed the Genialis Expressions software platform within its cloud infrastructure to support its drug development with biomarker discovery and multiomics data analytics. The agreement extends our companies' multi-year collaboration and pr
Read more
Report
Show more news

Tech stack

Technologies named in job postings at Debiopharm over the last 12 months, by layer, with the share of postings for each.
Technologies in use
7
Postings analysed
3
Stack modernity
58/100
Languages
Python
Cloud & platforms
GCP
Developer tools
Veeva
Practices & domains
CAPA
GLP
GMP
ICH Guidelines
Sign in to see how your skills match this stack Sign In

Growth

Hiring Momentum
79/100
Scaling fast
Open positions
5
1 opened / 0 closed in 30 days
Median time-to-fill
17 days
faster than 60% of the market
ATS activity
Every ~15 hours
10/24/2026
Hiring Dynamics +100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Biotech
57% ▼
Finance
14% ▼
Public Policy
14% ▼
Field & Service
14% ▲
Activity Timeline
Added Veeva to stack Oct 2026
Added ICH Guidelines to stack Oct 2026
Added GLP to stack Oct 2026
Added CAPA to stack Oct 2026
Added Python to stack Oct 2026
Added GCP to stack Oct 2026
Added GMP to stack Oct 2026
New location: Martigny Oct 2026
New location: Switzerland Oct 2026

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
2
Countries
1
Busiest office
Lausanne
Loading the map
Headquarters Builds here Office with open vacancies Tap a pin for the office
Lausanne Switzerland
Regional office
4 open roles 6 posted in 90 days 200-500 est. staff
hires for Biotech
seen since Jul 2026 job postings
Martigny Switzerland
Engineering / R&D
1 open roles 1 posted in 90 days 50-200 est. staff
hires for Field & Service
seen since Oct 2026 job postings

Jobs

≈ $40k – $71k per year (Estimated) • In office • Internship • Martigny
GMP
Apply
In office • Lausanne
GCP
Management
Agile
Life Sciences
GLP
ICH Guidelines
Veeva
MedTech
CAPA
Apply
In office • Lausanne
Python
GCP
Apply
In office • Full-Time • Lausanne
Apply